Flow Cytometry Market Growing at 9.4% CAGR to 2021
PUNE, India, July 22, 2016 /PRNewswire/ --
The global flow cytometry market is expected to reach $4.93 billion by 2021 from $3.14 billion in 2016, at a CAGR of 9.4% between 2016 and 2021 commanded by Asia-Pacific region that is expected to witness the highest growth rate during the forecast period fueled by improving healthcare infrastructure, favorable government initiatives, and growing focus of market players.
Complete report on global flow cytometry market spread across 185 pages, profiling 10 companies and supported with 106 tables and 35 figures is now available at http://www.marketreportshub.com/flow-cytometry-industry-research-marketsandmarkets.html .
The flow cytometry market is broadly segmented into products & services, technologies, applications, and end users. By products & services, the flow cytometry market is segmented into reagents & consumables, flow cytometry instruments, services, software, and accessories. The reagents & consumables segment is expected to command a major share of the flow cytometry market in 2016.
Geographically, the report covers four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global flow cytometry market in 2016, followed by Europe. The Asia-Pacific flow cytometry market is projected to witness the highest growth rate during the forecast period from 2016 to 2021 due to a number of factors, including improving healthcare infrastructure, favorable government initiatives, and growing focus of market players on the Asia-Pacific flow cytometry market.
In the flow cytometry industry, market growth is majorly driven by the development of novel flow cytometers, increasing use of flow cytometry in clinical trials, launch of new reagents for specific applications like diagnostics & drug discovery, development of user-friendly & intuitive software, growing prevalence of cancer& HIV/AIDS, and growing adoption of flow cytometry techniques in research activities.
As of 2015, the global flow cytometry market was dominated by Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.), which together held a share of 80% of the overall flow cytometry market. New product launches& product approvals; agreements, collaborations, & partnerships, geographic expansions; strategic acquisitions; and others (offering research grants& funds, awards & recognitions, and opening of new research centers to develop advanced flow cytometry solutions) are the major strategies adopted by most market players to achieve growth in the global flow cytometry market.
Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (U.S.), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), and Sony Biotechnology (U.S.) are the key players in the global flow cytometry market and profiled in this research report. Order a copy of Flow Cytometry Market by Technology (Cell & Bead-Based), Products (Analyzer, Sorter, Reagents, Consumables, Software), Application (Research, Clinical) & End User (Commercial Organization, Hospital, Clinical Testing Labs) - Global Forecasts to 2021 research report at http://www.marketreportshub.com/purchase?rpid=1925 .
Based on application, the global flow cytometry market is segmented into research applications, clinical applications, and industrial applications. In 2016, the research applications segment is expected to account for the largest share of the flow cytometry market, by application. The research applications segment is further sub segmented into pharmaceutical & biotechnology (drug discovery, in vitro toxicity testing, & stem cell research), apoptosis, immunology, cell cycle analysis, cell sorting, and cell viability. The clinical applications segment is further categorized into cancer, immunodeficiency diseases, hematology, and organ transplantation.
On a related note, another research on Stem Cell Banking Market Forecast to 2021 says, Processing services to contribute largest share in the stem cell bio banking market. North America is the largest contributor to the global stem cell banking market, while Asia-Pacific is the fastest-growing market segment. The global market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. Companies like StemCyte, Cryo-Cell International, ViaCord, Cord Blood Registry, Smart Cells, Cryo-Save, Cryoviva, LifeCell, Cordlife, Cordvida and China Cord Blood Corporation have been profiled in this 119 pages research report available at http://www.marketreportshub.com/stem-cell-banking-industry-research-marketsandmarkets.html .
Explore more reports on Life Sciences market at http://www.marketreportshub.com/categories/life-sciences .
Market Reports Hub is your one-stop online shop for syndicated industry research reports on 25+ categories and their sub-sectors. We bring to you to the latest in market research across multiple industries and geographies from leading research publishers across the globe.
Connect with Us:
G+ / Google Plus: https://plus.google.com/110654518968238222746/about
RSS / Feeds:http://www.marketreportshub.com/rss.xml
Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune - 411013 Maharashtra, India. Tel: +1-888-391-5441 email@example.com
SOURCE Market Reports Hub